| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |